192 related articles for article (PubMed ID: 28061356)
1. Clinical Differences in Autofluorescence Between Viable and Nonvital Bone: A Case Report With Histopathologic Evaluation Performed on Medication-Related Osteonecrosis of the Jaws.
Giovannacci I; Meleti M; Corradi D; Vescovi P
J Oral Maxillofac Surg; 2017 Jun; 75(6):1216-1222. PubMed ID: 28061356
[TBL] [Abstract][Full Text] [Related]
2. Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study.
Giudice A; Bennardo F; Barone S; Antonelli A; Figliuzzi MM; Fortunato L
J Oral Maxillofac Surg; 2018 May; 76(5):982-995. PubMed ID: 29175416
[TBL] [Abstract][Full Text] [Related]
3. Medication-Related Osteonecrosis of the Jaw: An Autofluorescence-Guided Surgical Approach Performed with Er:YAG Laser.
Vescovi P; Giovannacci I; Otto S; Manfredi M; Merigo E; Fornaini C; Nammour S; Meleti M
Photomed Laser Surg; 2015 Aug; 33(8):437-42. PubMed ID: 26226174
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
Yoshiga D; Sasaguri M; Matsuo K; Kokuryou S; Habu M; Oda M; Kodama M; Tsurushima H; Sakaguchi O; Sakurai T; Tanaka J; Morimoto Y; Yoshioka I; Tominaga K
Osteoporos Int; 2015 Jul; 26(7):1997-2006. PubMed ID: 26037792
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws.
Tomo S; da Cruz TM; Figueira JA; Cunha JLS; Miyahara GI; Simonato LE
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102003. PubMed ID: 32916330
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Atalay B; Yalcin S; Emes Y; Aktas I; Aybar B; Issever H; Mandel NM; Cetin O; Oncu B
Lasers Med Sci; 2011 Nov; 26(6):815-23. PubMed ID: 21809068
[TBL] [Abstract][Full Text] [Related]
8. Auto-Fluorescence and Histopathologic Evaluation of Medication-Related Osteonecrosis of the Jaws: Perspectives for Treatment.
Giovannacci I; Vescovi P; Magnoni C; Corradi D; Corcione L; Lucchina AG; Mortellaro C; Nammour S; Meleti M
J Craniofac Surg; 2019 Jun; 30(4):1039-1043. PubMed ID: 29944562
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
10. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).
Ristow O; Otto S; Troeltzsch M; Hohlweg-Majert B; Pautke C
J Craniomaxillofac Surg; 2015 Mar; 43(2):290-3. PubMed ID: 25541255
[TBL] [Abstract][Full Text] [Related]
11. Use of a generic violet light in the surgical management of medication-related osteonecrosis of the jaws: a technical note.
Ballardin C; Pereira-Stabile CL; Stabile GAV
Oral Maxillofac Surg; 2018 Dec; 22(4):477-481. PubMed ID: 30173371
[TBL] [Abstract][Full Text] [Related]
12. Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study.
Ristow O; Otto S; Geiß C; Kehl V; Berger M; Troeltzsch M; Koerdt S; Hohlweg-Majert B; Freudlsperger C; Pautke C
Int J Oral Maxillofac Surg; 2017 Feb; 46(2):157-166. PubMed ID: 27856150
[TBL] [Abstract][Full Text] [Related]
13. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.
Vescovi P; Manfredi M; Merigo E; Guidotti R; Meleti M; Pedrazzi G; Fornaini C; Bonanini M; Ferri T; Nammour S
Photomed Laser Surg; 2012 Jan; 30(1):5-13. PubMed ID: 22054203
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ).
Assaf AT; Zrnc TA; Riecke B; Wikner J; Zustin J; Friedrich RE; Heiland M; Smeets R; Gröbe A
J Craniomaxillofac Surg; 2014 Jul; 42(5):e157-64. PubMed ID: 24011463
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
[TBL] [Abstract][Full Text] [Related]
17. Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis.
Subramanian G; Kalyoussef E; Blitz-Goldstein M; Guerrero J; Ghesani N; Quek SY
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Mar; 123(3):e106-e116. PubMed ID: 28108142
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline fluorescence-guided Er:YAG laser ablation combined with Nd:YAG/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw.
Porcaro G; Amosso E; Scarpella R; Carini F
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e6-e12. PubMed ID: 25174873
[TBL] [Abstract][Full Text] [Related]
20. Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis.
de Souza Faloni AP; Queiroz TP; Comelli Lia RC; Cerri PS; Margonar R; Rastelli AN; Marcantonio E
J Craniofac Surg; 2011 Nov; 22(6):2185-90. PubMed ID: 22075816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
